Abstract
The application of fluorescence in situ hybridization (FISH) technology in diagnosis and molecular classification of cancer-risk has become an essential tool in the proceeding of personalized therapy. In multiple myeloma, the precise FISH detection of numerical and structural genetic aberrations can be carried out on metaphase chromosome spreads, interphase nuclei, and formalin fixed paraffin-embedded (FFPE) tissues. To dissect highly complex cancer genomes, a broad variety of novel DNA probes, which outpace supplies from commercial resources on the market, are also crucial to the advanced translational researches. Here, we provide the protocols for the creation of custom-made DNA probes and for conducting hybridizations on various targeting cells and tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Das KC, Aikat BK (1967) Chromosomal abnormalities in multiple myeloma. Blood 30(6):738–748
Philip P, Drivsholm A (1976) G-banding analysis of complex aneuploidy in multiple myeloma bone marrow cells. Blood 47(1):69–77
Liang W, Hopper JE, Rowley JD (1979) Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer 44(2):630–644
Dewald GW, Kyle RA, Hicks GA, Greipp PR (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66(2):380–390
Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B (1988) Plasma cell karyotype in multiple myeloma. Blood 71(2):453–456
Flactif M, Zandecki M, Lai JL, Bernardi F, Obein V, Bauters F, Facon T (1995) Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 9(12):2109–2114
Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85(9):2490–2497
Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A (1997) Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18(2):84–93
Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL (1997) Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16(3):260–264. https://doi.org/10.1038/ng0797-260
Feinman R, Sawyer J, Hardin J, Tricot G (1997) Cytogenetics and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am 11(1):1–25
Shaughnessy J, Tian E, Sawyer J, Bumm K, Landes R, Badros A, Morris C, Tricot G, Epstein J, Barlogie B (2000) High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood 96(4):1505–1511
Keung YK, Yung C, Wong JW, Shah F, Cobos E, Tonk V (1998) Unusual presentation of multiple myeloma with “jumping translocation” involving 1q21. A case report and review of the literature. Cancer Genet Cytogenet 106(2):135–139
Sawyer JR, Tricot G, Mattox S, Jagannath S, Barlogie B (1998) Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 91(5):1732–1741
Sawyer JR, Tricot G, Lukacs JL, Binz RL, Tian E, Barlogie B, Shaughnessy J Jr (2005) Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q. Genes Chromosomes Cancer 42(1):95–106. https://doi.org/10.1002/gcc.20109
Hanamura I, Stewart JP, Huang Y, Zhan F, Santra M, Sawyer JR, Hollmig K, Zangarri M, Pineda-Roman M, van Rhee F, Cavallo F, Burington B, Crowley J, Tricot G, Barlogie B, Shaughnessy JD Jr (2006) Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. Blood 108(5):1724–1732. https://doi.org/10.1182/blood-2006-03-009910
Tian E, Sawyer JR, Heuck CJ, Zhang Q, van Rhee F, Barlogie B, Epstein J (2014) In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes. Genes Chromosomes Cancer 53(7):549–557. https://doi.org/10.1002/gcc.22165
Osoegawa K, Mammoser AG, Wu C, Frengen E, Zeng C, Catanese JJ, de Jong PJ (2001) A bacterial artificial chromosome library for sequencing the complete human genome. Genome Res 11(3):483–496. https://doi.org/10.1101/gr.169601
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tian, E. (2018). Fluorescence In Situ Hybridization (FISH) in Multiple Myeloma. In: Heuck, C., Weinhold, N. (eds) Multiple Myeloma. Methods in Molecular Biology, vol 1792. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-7865-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7865-6_5
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-7864-9
Online ISBN: 978-1-4939-7865-6
eBook Packages: Springer Protocols